DBV

Beyond's analysis on DBV

• 2026-07-16 — DBV Technologies releases Q2 and H1 2026 financial results and a business update on its immunotherapy programs

Recent news mentioning DBV

• 2026-07-30 — DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
• 2026-07-30 — DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq

Appears alongside

• Nasdaq
• ATM

Browse the full archive →